Pityriasis Versicolor in Children and Adolescents: an Update

[1]  A. Velegraki,et al.  The lipid profile of three Malassezia species assessed by Raman spectroscopy and discriminant analysis. , 2019, Molecular and cellular probes.

[2]  M. Mathur,et al.  Dermoscopic pattern of pityriasis versicolor , 2019, Clinical, cosmetic and investigational dermatology.

[3]  T. Dawson.  Malassezia: The Forbidden Kingdom Opens. , 2019, Cell host & microbe.

[4]  G. Jameel,et al.  Phenotypic Identification and Molecular Characterization of Malassezia Spp. Isolated from Pityriasis Versicolor Patients with Special Emphasis to Risk Factors in Diyala Province, Iraq , 2019, Open access Macedonian journal of medical sciences.

[5]  B. Piraccini,et al.  Tinea versicolor of the neck as side effect of topical steroids for alopecia areata , 2019, The Journal of dermatological treatment.

[6]  A. Vojvodić,et al.  Distribution of Malassezia Species from Scales of Patient with Pityriasis Versicolor by Culture in Vietnam , 2019, Open access Macedonian journal of medical sciences.

[7]  A. Vojvodić,et al.  Efficacy of Azole Antifungal in Treatment of Pityriasis Versicolor , 2019, Open access Macedonian journal of medical sciences.

[8]  S. Ranque,et al.  MALDI-TOF MS identification of Malassezia species isolated from patients with pityriasis versicolor at the seafarers' medical service in Dakar, Senegal. , 2018, Journal de mycologie medicale.

[9]  S. Dogra,et al.  Identification of Malassezia species by MALDI-TOF MS after expansion of database. , 2018, Diagnostic microbiology and infectious disease.

[10]  S. Seyedmousavi,et al.  MGL_3741 gene contributes to pathogenicity of Malassezia globosa in pityriasis versicolor , 2018, Mycoses.

[11]  C. Pereira,et al.  Fungal diseases in children and adolescents in a referral centre in Bogota, Colombia , 2018, Mycoses.

[12]  T. Boekhout,et al.  Malassezia ecology, pathophysiology, and treatment. , 2018, Medical mycology.

[13]  J. Palmer,et al.  Malassezia vespertilionis sp. nov.: a new cold-tolerant species of yeast isolated from bats , 2018, Persoonia.

[14]  J. Bouchara,et al.  Malassezia species in students from universities of Sabzevar, Northeastern Iran. , 2018, Journal de mycologie medicale.

[15]  D. González-Vilas,et al.  Pitiriasis versicolor atrófica , 2017, Actas Dermo-Sifiliográficas.

[16]  V. Martínez,et al.  Pitiriasis versicolor: una actualización , 2018 .

[17]  L. Angiolella,et al.  Biofilm, adherence, and hydrophobicity as virulence factors in Malassezia furfur , 2018, Medical mycology.

[18]  E. Grice,et al.  Host-microbe interactions: Malassezia and human skin. , 2017, Current opinion in microbiology.

[19]  S. Leibundgut-Landmann,et al.  Host Responses to Malassezia spp. in the Mammalian Skin , 2017, Front. Immunol..

[20]  G. Benard,et al.  Recurrent and disseminated pityriasis versicolor: A novel clinical form consequent to Malassezia-host interaction? , 2017, Medical hypotheses.

[21]  W. Elshabrawy,et al.  Molecular and Phenotypic Identification and Speciation of Malassezia Yeasts Isolated from Egyptian Patients with Pityriasis Versicolor. , 2017, Journal of clinical and diagnostic research : JCDR.

[22]  H. Yahya.  Knowledge, perception, and practice of patients about pityriasis versicolor in Kaduna, North Central Nigeria , 2017, International journal of dermatology.

[23]  Z. Bagheri,et al.  Comparative efficacy of topical application of tacrolimus and clotrimazole in the treatment of pityriasis versicolor: A single blind, randomised clinical trial , 2017, Mycoses.

[24]  C. Magro,et al.  Atrophying pityriasis versicolor as an idiosyncratic T cell–mediated response to Malassezia: A case series , 2017, Journal of the American Academy of Dermatology.

[25]  G. M. Chaves,et al.  Epidemiology and fungal species distribution of superficial mycoses in Northeast Brazil. , 2017, Journal de mycologie medicale.

[26]  S. Piaserico,et al.  Atrophic pityriasis versicolor occurring in a patient with Sjögren's syndrome , 2017, BMJ Case Reports.

[27]  Somenath Sarkar,et al.  Comparative assessment of the efficacy of topical ketoconazole and topical luliconazole in cases of pityriasis versicolor at a tertiary care hospital in eastern India: A prospective, open, randomized controlled trial , 2016, Indian dermatology online journal.

[28]  S. Dogra,et al.  Malassezia arunalokei sp. nov., a Novel Yeast Species Isolated from Seborrheic Dermatitis Patients and Healthy Individuals from India , 2016, Journal of Clinical Microbiology.

[29]  G. Ahmed,et al.  Clinicomycological profile of pityriasis versicolor in Assam , 2016, Indian journal of pathology & microbiology.

[30]  T. C. Daboit,et al.  SIXTEEN YEARS OF PITYRIASIS VERSICOLOR IN METROPOLITAN AREA OF PORTO ALEGRE, SOUTHERN BRAZIL , 2015, Revista do Instituto de Medicina Tropical de Sao Paulo.

[31]  M. Bigby,et al.  Pityriasis versicolor , 2015, BMJ : British Medical Journal.

[32]  Aditya K. Gupta,et al.  Antifungal Treatment for Pityriasis Versicolor , 2015, Journal of fungi.

[33]  Yongbo Tang,et al.  A randomized controlled trial of combination treatment with ketoconazole 2% cream and adapalene 0.1% gel in pityriasis versicolor , 2015, The Journal of dermatological treatment.

[34]  T. Ruzicka,et al.  The spectrum of Malassezia species isolated from students with pityriasis vesicolor in Nigeria , 2015, Mycoses.

[35]  Zoulikha Zarrab,et al.  Tinea Versicolor (Pityriasis Versicolor) , 2015 .

[36]  M. Arendrup,et al.  Evidence-based Danish guidelines for the treatment of Malassezia-related skin diseases. , 2015, Acta dermato-venereologica.

[37]  Guoyin Wang,et al.  Erratum to “Experimental Analyses of the Major Parameters Affecting the Intensity of Outbursts of Coal and Gas” , 2014, The Scientific World Journal.

[38]  H. Zhang,et al.  An Analysis of the Malassezia Species Distribution in the Skin of Patients with Pityriasis Versicolor in Chengdu, China , 2014, TheScientificWorldJournal.

[39]  Aditya K. Gupta,et al.  Pityriasis versicolor: an update on pharmacological treatment options , 2014, Expert opinion on pharmacotherapy.

[40]  A. Gonçalves Rodrigues,et al.  Malassezia infections: a medical conundrum. , 2014, Journal of the American Academy of Dermatology.

[41]  M. Saraçlı,et al.  Distribution of Malassezia species in patients with pityriasis versicolor in Turkey. , 2014, Journal de mycologie medicale.

[42]  A. Bonifaz,et al.  Pitiriasis versicolor variedad atrófica: A propósito de un caso , 2014 .

[43]  C. Romano,et al.  Identification of Malassezia species isolated from patients with extensive forms of pityriasis versicolor in Siena, Italy. , 2013, Revista iberoamericana de micologia.

[44]  Juliano Oliveira Santana,et al.  Pityriasis versicolor: clinical-epidemiological characterization of patients in the urban area of Buerarema-BA, Brazil , 2013, Anais brasileiros de dermatologia.

[45]  B. Piraccini,et al.  Pityriasis versicolor during anti‐TNF‐α monoclonal antibody therapy: therapeutic considerations , 2012, Mycoses.

[46]  Toshiyuki Yamamoto,et al.  Transepidermal elimination of sarcoidal granuloma in a patient with sarcoidosis and systemic sclerosis overlap. , 2012, European journal of dermatology : EJD.

[47]  A. Brinca,et al.  Pityriasis versicolor atrophicans. , 2012, European journal of dermatology : EJD.

[48]  Carlos Porras,et al.  Pitiriasis versicolor: estudio de 194 casos con insistencia en la discromía , 2012 .

[49]  M. Sortino,et al.  Prevalence of Malassezia species in patients with pityriasis versicolor in Rosario, Argentina. , 2012, Revista Iberoamericana de Micologia.

[50]  V. Framil,et al.  Novos aspectos na evolução clínica da pitiríase versicolor , 2011 .

[51]  Do Won Kim,et al.  Disruption of barrier function in dermatophytosis and pityriasis versicolor , 2011, The Journal of dermatology.

[52]  S. Feldman.  It isn't a perfect world , 2011 .

[53]  R. Gasser,et al.  Advances in the identification of Malassezia. , 2011, Molecular and cellular probes.

[54]  R. Negroni.  Historical aspects of dermatomycoses. , 2010, Clinics in dermatology.

[55]  J. Quiring,et al.  A double-blind, randomized, placebo-controlled, dose-finding study of oral pramiconazole in the treatment of pityriasis versicolor. , 2009, Journal of the American Academy of Dermatology.

[56]  M. Durdu,et al.  Epidemiology of pityriasis versicolor in Adana, Turkey , 2009, The Journal of dermatology.

[57]  V. Crespo-Erchiga,et al.  CONTROVERSIAS EN DERMATOLOGÍA La pitiriasis versicolor y las levaduras del género Malassezia , 2008 .

[58]  P. Jaen,et al.  Discoid lupus erythematosus: good response to treatment with photodynamic therapy , 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.

[59]  A. Chuh,et al.  Pityriasis versicolor imbricata – overlapping parallel scales in a novel variant of pityriasis versicolor , 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.

[60]  M. Mokni,et al.  Penile shaft involvement in pityriasis versicolor. , 2008, Acta dermatovenerologica Alpina, Pannonica, et Adriatica.

[61]  F. Xiao,et al.  The genetic epidemiology of tinea versicolor in China , 2007, Mycoses.

[62]  P. Schmid‐Grendelmeier,et al.  Skin disorders among school children in rural Tanzania and an assessment of therapeutic needs , 2006, Tropical doctor.

[63]  M. Ram,et al.  Pityriasis versicolor in the pediatric age group. , 2005, Indian journal of dermatology, venereology and leprology.

[64]  P. Mayser,et al.  Pityriasis versicolor alba , 2005, Journal of the European Academy of Dermatology and Venereology : JEADV.

[65]  Aditya K. Gupta,et al.  Pityriasis versicolor: a review of pharmacological treatment options , 2005, Expert opinion on pharmacotherapy.

[66]  Sandra M. Johnson,et al.  A double-blind comparative study of sodium sulfacetamide lotion 10% versus selenium sulfide lotion 2.5% in the treatment of pityriasis (tinea) versicolor. , 2004, Cutis.

[67]  A. Hasegawa,et al.  Malassezia nana sp. nov., a novel lipid-dependent yeast species isolated from animals. , 2004, International journal of systematic and evolutionary microbiology.

[68]  C. Magro,et al.  Atrophying tinea versicolor: A clinical and histological study of 12 patients , 2003, International journal of dermatology.

[69]  M. Takashima,et al.  Description of a New Yeast Species, Malassezia japonica, and Its Detection in Patients with Atopic Dermatitis and Healthy Subjects , 2003, Journal of Clinical Microbiology.

[70]  M. Haberal,et al.  Superficial fungal infections in 102 renal transplant recipients: a case-control study. , 2003, Journal of the American Academy of Dermatology.

[71]  R. Summerbell,et al.  Pityriasis versicolor , 2002, Journal of the European Academy of Dermatology and Venereology : JEADV.

[72]  R. Summerbell,et al.  Onychomycosis: strategies to improve efficacy and reduce recurrence , 2002, Journal of the European Academy of Dermatology and Venereology : JEADV.

[73]  H. Suto,et al.  New Yeast Species, Malassezia dermatis, Isolated from Patients with Atopic Dermatitis , 2002, Journal of Clinical Microbiology.

[74]  E. Evans,et al.  Immunology of Diseases Associated with Malassezia Species , 2002, Clinical Microbiology Reviews.

[75]  M. Abdulghani,et al.  Pigmentary changes of tinea versicolor in dark‐skinned patients , 2001, International journal of dermatology.

[76]  B. Amichai.  Treatment of pityriasis versicolor with a shampoo containing 1% bifonazole (AgisporR shampoo) in children , 2000, Clinical and experimental dermatology.

[77]  A. Katsambas,et al.  ECONAZOLE 1% SHAMPOO VERSUS SELENIUM IN THE TREATMENT OF TINEA VERSICOLOR: A SINGLE‐BLIND RANDOMIZED CLINICAL STUDY , 1996, International journal of dermatology.

[78]  K. Hashimoto,et al.  TINEA VERSICOLOR: HISTOLOGIC AND ULTRASTRUCTURAL INVESTIGATION OF PIGMENTARY CHANGES , 1992, International journal of dermatology.

[79]  Rizwana,et al.  An open study of tioconazole 1% dermal cream in patients with pityriasis versicolor. , 1984, JPMA. The Journal of the Pakistan Medical Association.

[80]  H. Congly.  Pityriasis versicolor in a 3-month-old boy. , 1984, Canadian Medical Association journal.

[81]  K. Takamori,et al.  DE‐(HYPO)PIGMENTATION MECHANISMS OF THE AFFECTED AREA OF PITYRIASIS VERSICOLOR , 1984, The Journal of dermatology.

[82]  L. Hellgren,et al.  The incidence of tinea versicolor in central Sweden. , 1983, Journal of medical microbiology.

[83]  A. Prestia.  Topical benzoyl peroxide for the treatment of tinea versicolor. , 1983, Journal of the American Academy of Dermatology.

[84]  H. W. Wyre,et al.  Neonatal pityriasis versicolor. , 1981, Archives of dermatology.

[85]  R. Clayton,et al.  Double-blind trial of 1% clotrimazole cream and Whitfield ointment in the treatment of pityriasis versicolor. , 1977, Archives of dermatology.